The influence of metabolic syndrome in the outcomes of colorectal cancer patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/1822/49012 |
Resumo: | Aims: Determine the influence of metabolic syndrome and its different components in the outcomes of colorectal cancer surgery at 30 days. Materials and methods: Prospective study that included all patients submitted to elective colorectal cancer surgery between August 2015 and August 2016 at Hospital de Braga. Clinical and laboratory parameters evaluated pre-operatively were: central obesity, blood pressure, fasting glucose, triglycerides levels and HDL cholesterol levels. Any complications during the first 30-days after surgery were recorded (readmission, reintervention, anastomotic dehiscence, morbimortality). Results: One hundred and thirty-four patients were included. Metabolic syndrome was diagnostic in 40.7% of patients with the ATPIII definition, 67.5% with the AHA definition and 67.0% with the IDF definition. At 30 days after colorectal cancer surgery, 73.1% patients don't have any complication, 15.7% have minor complications (grade I/II of Clavien-Dindo classification), 11.1% have major complications (grade III/IV/V of Clavien-Dindo classification) and 1.5% have died from surgical complications (grade V of Clavien-Dindo classification). The statistic analysis didn't reveal any association between MS, or it's different components, and surgical outcomes. Conclusion: This study seems to indicate that metabolic syndrome don't have any influence in surgical outcomes of colorectal cancer surgery. (C) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved. |
id |
RCAP_04869e0183f34b10dc179e2351db17e9 |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/49012 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The influence of metabolic syndrome in the outcomes of colorectal cancer patientsMetabolic syndromeColorectal cancerCiências Médicas::Medicina BásicaScience & TechnologyAims: Determine the influence of metabolic syndrome and its different components in the outcomes of colorectal cancer surgery at 30 days. Materials and methods: Prospective study that included all patients submitted to elective colorectal cancer surgery between August 2015 and August 2016 at Hospital de Braga. Clinical and laboratory parameters evaluated pre-operatively were: central obesity, blood pressure, fasting glucose, triglycerides levels and HDL cholesterol levels. Any complications during the first 30-days after surgery were recorded (readmission, reintervention, anastomotic dehiscence, morbimortality). Results: One hundred and thirty-four patients were included. Metabolic syndrome was diagnostic in 40.7% of patients with the ATPIII definition, 67.5% with the AHA definition and 67.0% with the IDF definition. At 30 days after colorectal cancer surgery, 73.1% patients don't have any complication, 15.7% have minor complications (grade I/II of Clavien-Dindo classification), 11.1% have major complications (grade III/IV/V of Clavien-Dindo classification) and 1.5% have died from surgical complications (grade V of Clavien-Dindo classification). The statistic analysis didn't reveal any association between MS, or it's different components, and surgical outcomes. Conclusion: This study seems to indicate that metabolic syndrome don't have any influence in surgical outcomes of colorectal cancer surgery. (C) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.info:eu-repo/semantics/publishedVersionElsevierUniversidade do MinhoGoulart, AndréVarejão, AnaNogueira, FernandaMartins, SandraMesquita-Rodrigues, AntónioSousa, NunoLeão, Pedro2017-12-072017-12-07T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/49012engGoulart, A., Varejão, A., Nogueira, F., Martins, S., Mesquita-Rodrigues, A., Sousa, N., & Leão, P. (2017). The influence of metabolic syndrome in the outcomes of colorectal cancer patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11, S867-S871.1871-402110.1016/j.dsx.2017.07.00728711516https://www.sciencedirect.com/science/article/pii/S1871402117301765info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:12:36Zoai:repositorium.sdum.uminho.pt:1822/49012Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:04:32.893478Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The influence of metabolic syndrome in the outcomes of colorectal cancer patients |
title |
The influence of metabolic syndrome in the outcomes of colorectal cancer patients |
spellingShingle |
The influence of metabolic syndrome in the outcomes of colorectal cancer patients Goulart, André Metabolic syndrome Colorectal cancer Ciências Médicas::Medicina Básica Science & Technology |
title_short |
The influence of metabolic syndrome in the outcomes of colorectal cancer patients |
title_full |
The influence of metabolic syndrome in the outcomes of colorectal cancer patients |
title_fullStr |
The influence of metabolic syndrome in the outcomes of colorectal cancer patients |
title_full_unstemmed |
The influence of metabolic syndrome in the outcomes of colorectal cancer patients |
title_sort |
The influence of metabolic syndrome in the outcomes of colorectal cancer patients |
author |
Goulart, André |
author_facet |
Goulart, André Varejão, Ana Nogueira, Fernanda Martins, Sandra Mesquita-Rodrigues, António Sousa, Nuno Leão, Pedro |
author_role |
author |
author2 |
Varejão, Ana Nogueira, Fernanda Martins, Sandra Mesquita-Rodrigues, António Sousa, Nuno Leão, Pedro |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Goulart, André Varejão, Ana Nogueira, Fernanda Martins, Sandra Mesquita-Rodrigues, António Sousa, Nuno Leão, Pedro |
dc.subject.por.fl_str_mv |
Metabolic syndrome Colorectal cancer Ciências Médicas::Medicina Básica Science & Technology |
topic |
Metabolic syndrome Colorectal cancer Ciências Médicas::Medicina Básica Science & Technology |
description |
Aims: Determine the influence of metabolic syndrome and its different components in the outcomes of colorectal cancer surgery at 30 days. Materials and methods: Prospective study that included all patients submitted to elective colorectal cancer surgery between August 2015 and August 2016 at Hospital de Braga. Clinical and laboratory parameters evaluated pre-operatively were: central obesity, blood pressure, fasting glucose, triglycerides levels and HDL cholesterol levels. Any complications during the first 30-days after surgery were recorded (readmission, reintervention, anastomotic dehiscence, morbimortality). Results: One hundred and thirty-four patients were included. Metabolic syndrome was diagnostic in 40.7% of patients with the ATPIII definition, 67.5% with the AHA definition and 67.0% with the IDF definition. At 30 days after colorectal cancer surgery, 73.1% patients don't have any complication, 15.7% have minor complications (grade I/II of Clavien-Dindo classification), 11.1% have major complications (grade III/IV/V of Clavien-Dindo classification) and 1.5% have died from surgical complications (grade V of Clavien-Dindo classification). The statistic analysis didn't reveal any association between MS, or it's different components, and surgical outcomes. Conclusion: This study seems to indicate that metabolic syndrome don't have any influence in surgical outcomes of colorectal cancer surgery. (C) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-12-07 2017-12-07T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1822/49012 |
url |
http://hdl.handle.net/1822/49012 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Goulart, A., Varejão, A., Nogueira, F., Martins, S., Mesquita-Rodrigues, A., Sousa, N., & Leão, P. (2017). The influence of metabolic syndrome in the outcomes of colorectal cancer patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11, S867-S871. 1871-4021 10.1016/j.dsx.2017.07.007 28711516 https://www.sciencedirect.com/science/article/pii/S1871402117301765 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132454785646592 |